Every two weeks, data is released on the level of short interest in specific stocks. You can find this data in places like the Wall Street Journal, for example. It can clue you into possible problems ahead, but it can also spell opportunity. If the short-sellers are wrong, you can… Read More
David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon
Analyst Articles
The Perfect Way to Short Nuclear Power Stocks
About 20% of the world’s energy supply comes from 440 nuclear power plants, located in 25 countries around the world. About 12% of these nuclear reactors are in Japan. As the headlines describe, the devastating earthquake and tsunami that struck Japan on March 11 triggered a series of explosions, leading to the partial meltdown of a nuclear plant, located 150 miles outside of Tokyo. The impact of the meltdown has spread far beyond Japan, affecting nuclear-power companies worldwide. Observers suspected plans for many of the world’s 60 new nuclear plants could be stopped, or at the very least halted, for… Read More
About 20% of the world’s energy supply comes from 440 nuclear power plants, located in 25 countries around the world. About 12% of these nuclear reactors are in Japan. As the headlines describe, the devastating earthquake and tsunami that struck Japan on March 11 triggered a series of explosions, leading to the partial meltdown of a nuclear plant, located 150 miles outside of Tokyo. The impact of the meltdown has spread far beyond Japan, affecting nuclear-power companies worldwide. Observers suspected plans for many of the world’s 60 new nuclear plants could be stopped, or at the very least halted, for some time to come. This week, the Swiss government announced the suspension of approvals for new nuclear plants. The German government followed suit. Furthermore, Germany’s seven nuclear facilities, built prior to 1980, will be shut down until at least May. This step leaves the country with only 10 operating nuclear facilities. In France — where 80% of the country’s electricity comes from nuclear power — the Green Party has called for a referendum on the future of nuclear power. And even China, which has had big ambitions for nuclear power-expansion, announced Wednesday, March 16, that it was… Read More
5 Reasons I’m Still Bullish on Uranium Stocks
A couple of weeks ago, I spelled out the case for rising uranium prices. Then, tragedy struck. As you know, Northeast Japan suffered a devastating 9.0 magnitude earthquake on March 11, which unleashed a monster 30-foot tsunami that wiped out everything in its path. Read More
These 3 Stocks are Absolute Bargains
There are many investing maxims, but my favorite one will always be “love stocks when they’re hated.” That usually refers to bear markets being great buying opportunities, as we saw in early 2009 when the market finally began to turn around. Yet, the… Read More
The unfolding events in Japan are distressing and saddening. We all hope that the social, environmental and economic impact of the recent earthquake will prove to be not as bad as is currently feared. In times like this, one can become a bit squeamish talking about investing. The sheer notion… Read More
The ONLY Stocks You Should Own in This Sector
Large pharmaceutical companies are facing a crisis. The industry spent a record $65 billion on research and development (R&D) in 2009, but approval rates for new drugs have fallen 44% during the past decade and continue to drop. Also in 2009, drugs launched in the previous five years accounted for… Read More
The “Other” Yield You Should Pay Attention To…
It was in an e-mail I received from one of my Daily Paycheck subscribers the other day. I thought it was a great suggestion. “Would you please consider displaying yield in the portfolios as both ‘current yield‘ and ‘… Read More
I got to know one company on my current watch list very well one summer, while working in the mail room of my father’s law firm. This was the mid 1980s. E-mail wasn’t even a Jetson’s fantasy. The computers that were around at the time were as big as a… Read More
2 Of My Favorite “Real Asset” Stocks For 2011
This has been quite a winter. From Arab states falling to Twitter revolutions, to U.S. states finally owning up to their own fiscal shortfalls, to natural disasters in New Zealand, Australia and now Japan, stock markets around the world have been swinging up and down in manic… Read More
What You Need to Know About the Market This Spring
As impressive as the stock market looked when it is was rising ever higher in 2009 and 2010, recent trading action has been even more impressive. Sure, the S&P 500 has gone nowhere for the past six weeks, but it has hung in there despite a series of shocks that… Read More